Literature DB >> 17563751

p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm.

C A Perez1, J Ott, D J Mays, J A Pietenpol.   

Abstract

p53 and p63 belong to a family of sequence-specific transcription factors regulating key cellular processes. Differential composition of the p53 and p63 DNA-binding sites may contribute to distinct functions of these protein homologues. We used SELEX (systematic evolution of ligands by exponential enrichment) methodology to identify nucleic acid ligands for p63. We found that p63 bound preferentially to DNA fragments conforming to the 20 bp sequence 5'-RRRC(A/G)(A/T)GYYYRRRC(A/T)(C/T)GYYY-3'. Relative to the p53 consensus, the p63 consensus DNA-binding site (DBS) was more degenerate, particularly at positions 10 and 11, and was enriched for A/G at position 5 and C/T at position 16 of the consensus. The differences in DNA-binding site preferences between p63 and p53 influenced their ability to activate transcription from select response elements (REs) in cells. A computer algorithm, p63MH, was developed to find candidate p63-binding motifs on input sequences. We identified genes responsive to p63 regulation that contain functional p63 REs. Our results suggest that the sequence composition of REs could be one contributing factor to target gene discrimination between p63 and p53.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563751     DOI: 10.1038/sj.onc.1210561

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

1.  A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.

Authors:  Bi-He Cai; Chung-Faye Chao; Hwang-Chi Lin; Hua-Ying Huang; Reiji Kannagi; Jang-Yi Chen
Journal:  J Biochem       Date:  2016-01-27       Impact factor: 3.387

2.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

3.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

4.  ΔNp63α down-regulates c-Myc modulator MM1 via E3 ligase HERC3 in the regulation of cell senescence.

Authors:  Yonglong Chen; Yimin Li; Yougong Peng; Xuan Zheng; Shijie Fan; Yong Yi; Peng Zeng; Hu Chen; Han Kang; Yujun Zhang; Zhi-Xiong Xiao; Chenghua Li
Journal:  Cell Death Differ       Date:  2018-06-07       Impact factor: 15.828

Review 5.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

6.  Structures of p63 DNA binding domain in complexes with half-site and with spacer-containing full response elements.

Authors:  Chen Chen; Natalia Gorlatova; Zvi Kelman; Osnat Herzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

7.  ΔNp63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.

Authors:  Gary X Wang; Ho-Chou Tu; Yiyu Dong; Anders Jacobsen Skanderup; Yufeng Wang; Shugaku Takeda; Yogesh Tengarai Ganesan; Song Han; Han Liu; James J Hsieh; Emily H Cheng
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Kendell Clement; Michael J Ziller; Patrick Boyle; Jean Fan; Hongcang Gu; Kristen Stevenson; Carrie Sougnez; Lili Wang; Shuqiang Li; Dylan Kotliar; Wandi Zhang; Mahmoud Ghandi; Levi Garraway; Stacey M Fernandes; Kenneth J Livak; Stacey Gabriel; Andreas Gnirke; Eric S Lander; Jennifer R Brown; Donna Neuberg; Peter V Kharchenko; Nir Hacohen; Gad Getz; Alexander Meissner; Catherine J Wu
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

Review 9.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

10.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.